iRhythm and Verily announced a partnership last month to "co-develop solutions intended to provide early warning, diagnosis and management for patients, particularly for those with silent or undiagnosed AF." We spoke with iRhythm CEO Kevin King to understand how the two companies complement each other and how they can solve the problem together. Ben Ouyang, Medgadget: Tell us about yourself. Kevin King: I've been CEO of iRhythm now for seven years, since the very early days when our company was private. I’ve led the company's growth and expansion to where...Read More

October 11th, 2019 by Medgadget Editors
Carbon monoxide (CO) is one of the most common substances that people are poisoned by. It has no smell and is invisible to the naked eye, but can cause severe damage to tissues and lead to death. Patients who have already suffered significant lung damage because of CO inhalation too often don't respond sufficiently to pure oxygen. Now, researchers at Massachusetts General Hospital have shown that a new device that treats patient blood using visible light works better that standard of care oxygen therapy. The research, so far performed in...Read More

October 11th, 2019 by Medgadget Editors
Kids with autism can become unruly and aggressive, often without any warnings for those around them. Such outbursts can also be emotionally difficult for family and caretakers, not just the kids, and planning events and going into public places is a major challenge. Having a bit of warning about an autistic child's worsening mental state may help to mitigate and even prevent outbursts. Using the Q-Sensor wrist-worn monitor from Affectiva, a company based in Cambridge, Massachusetts, researchers at the University of Missouri have been able to identify increased electrodermal activity...Read More
Medtronic has filed for FDA approval for its InterStim Micro neurostimulator and the accompanying InterStim SureScan MRI leads. The rechargeable device delivers sacral neuromodulation therapy to treat conditions such as overactive bladder, fecal incontinence, unobstructed urinary retention, and urinary urge incontinence. Along with the InterStim Micro, the new leads allow patients with the implanted system to safely receive MRI scans, given certain precautions. Sacral stimulation involves modulating signals passed between the brain, bowel, and bladder, improving performance of the underlying muscles. Because the new implant is 80% smaller than the...Read More

October 10th, 2019 by Medgadget Editors
Modern clinical MRIs usually have magnetic field strengths of 1.5 or 3.0 Tesla. These are pretty powerful magnets and it's the reason that these devices are very expensive. While such strengths have been standard for a long time, the internal hardware and software beyond the magnets have been improving steadily. Now, researchers affiliated with the National Institutes of Health have worked with a team at Siemens to see what a modern MRI, operating at a lower strength, is capable of. It may make sense to build weaker MRIs in order...Read More

October 10th, 2019 by Medgadget Editors
Dexcom landed FDA clearance for its Dexcom G6 Pro continuous glucometry system. Intended to be used by medical professionals with their patients, it offers a novel "blinded" mode that allows physicians to hide live glucose readings from patients. Using this capability, doctors can review glucometry data and propose lifestyle changes to patients following an up-to 10 day test period. In the meantime, patients don't have to worry about what their glucometer is reading and so won't be making potentially dangerous decisions on their own. The blinded mode is optional and...Read More
Most drugs are administered in pill form, but some have to be injected because they would otherwise be broken down by the gastrointestinal tract. This limitation mostly applies to protein-based drugs. Insulin, essentially a small protein (aka peptide), is by far the most injected medication in the world. It saves lives, but injections can be pretty brutal on many people with diabetes, particularly young children and elderly people. Now, researchers at MIT and Novo Nordisk, the Danish company that effectively controls the insulin market, have joined forces to create a...Read More
Radiotherapy is a well established method for attacking tumors within the body. There are a number of techniques that are used to administer radiation to a lesion, but they all come with the risk of injuring nearby tissues and organs. Gamma beams and other directed high energy devices result in the exposure of all the tissues that are on the way to and on the other side of a target, which is a serious problem. Knowing where the important organs are in individual patients can allow clinicians to prepare radiation...Read More

October 8th, 2019 by Medgadget Editors
Clinical researchers are constantly thwarted by the inability to quickly and easily try new therapies in tumors and other disease targets. Tumors within the brain are particularly hard to study because of the difficulty with access and the incredible fragility of nearby tissues. Researchers at Tufts University have just developed a way to create an environment that closely mimics that of the brain and were able to grow pediatric and adult tumors within it. The microenvironment allows for non-invasive imaging of the tumors and for easy manipulation of the cells...Read More
Gore won the European CE Mark for its GORE CARDIOFORM ASD Occluder, a device designed for percutaneous, transcatheter closure of ostium secundum atrial defects (ASDs). The occluder recently completed a clinical study involving 125 patients with ASD, ranging from 2 to 84 years of age, all of whom were successfully implanted with the GORE CARDIOFORM ASD and maintained closure six months later. The device is made of two discs that make contact with the tissue walls on both sides of the opening and, when engaged, come together to block the...Read More
Epica, a company based in San Clemente, California, won FDA clearance for its SeeFactorCT3 system that combines computed tomography (CT), fluoroscopy, and digitial radiography (DR) into a single device. It is intended for use in diagnostic, interventional, and intraoperative procedures mostly involving the head, neck, and extremities. As such, it is expected to be used by a variety of surgeons, dentists, and imaging specialists. The SeeFactorCT3 produces sliceless CT images, unlike typical CT systems, which means that there's no interpolation involved and therefore less chance of introducing artifacts. Isotropic imaging...Read More

« Older EntriesNewer Entries »




Emergency Medicine



Holler Box


Exclusive Medgadget news in your mailbox!

Your information will never be shared with any third party.